Healthcare & Life Sciences

Granular Therapeutics Limited

acquired

About

Granular Therapeutics Limited develops antibody therapeutics that selectively target mast cells to modulate immune responses in chronic inflammatory diseases.

Explore Granular Therapeutics Limited's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.